Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Titel:
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Auteur:
Qin, Shukui Chen, Minshan Cheng, Ann-Lii Kaseb, Ahmed O Kudo, Masatoshi Lee, Han Chu Yopp, Adam C Zhou, Jian Wang, Lu Wen, Xiaoyu Heo, Jeong Tak, Won Young Nakamura, Shinichiro Numata, Kazushi Uguen, Thomas Hsiehchen, David Cha, Edward Hack, Stephen P Lian, Qinshu Ma, Ning Spahn, Jessica H Wang, Yulei Wu, Chun Chow, Pierce K H